Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of CAIV-T Influenza Vaccine in Day Care Children
NCT00192283Phase 3Completed
- Sponsor
- MedImmune
- Start
- Sep 2000
- Primary completion
- Apr 2002
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing CAIV-T with Placebo (2 arms). Primary endpoint: First episode of culture-confirmed influenza illness. Started Sep 2000; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192283.